Amplify Weight Loss Drug & Treatment ETF (THNR)
| Assets | $4.16M |
| Expense Ratio | 0.59% |
| PE Ratio | 31.63 |
| Shares Out | 180,000 |
| Dividend (ttm) | $0.22 |
| Dividend Yield | 0.96% |
| Ex-Dividend Date | Dec 30, 2024 |
| Payout Ratio | 29.74% |
| 1-Year Return | n/a |
| Volume | 722 |
| Open | 23.29 |
| Previous Close | 23.09 |
| Day's Range | 23.23 - 23.47 |
| 52-Week Low | 22.00 |
| 52-Week High | 28.19 |
| Beta | n/a |
| Holdings | 30 |
| Inception Date | May 21, 2024 |
About THNR
Fund Home PageThe Amplify Weight Loss Drug & Treatment ETF (THNR) is an exchange-traded fund that is based on the VettaFi Weight Loss Drug index. The fund tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses. THNR was launched on May 21, 2024 and is issued by Amplify Investments.
Top 10 Holdings
72.58% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 17.35% |
| Novo Nordisk A/S | NVO | 12.60% |
| Chugai Pharmaceutical Co., Ltd. | 4519 | 6.00% |
| Roche Holding AG | ROG | 5.98% |
| AstraZeneca PLC | AZN | 5.74% |
| Amgen Inc. | AMGN | 5.72% |
| Pfizer Inc. | PFE | 5.37% |
| Thermo Fisher Scientific Inc. | TMO | 5.25% |
| Merck & Co., Inc. | MRK | 4.58% |
| FUJIFILM Holdings Corporation | 4901 | 3.99% |
News
New Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFs
For many of us, a new year often means a new chance to start fresh in our battle with weight. Thanks to interesting ETF product development, especially in the past year, it could also mean a chance to...
Disruptive Theme of the Week: 2024's Top Investment Themes & Trends
2024 was an amazing year for investment performance, with the broad market S&P 500 TR Index up over 28%. There were also some serious ETF milestones achieved this year.
SILJ, HACK, THNR: Trends in Thematic Investing
Amplify Junior Silver Miners ETF (SILJ) is up 28% year-to-date. Christian Magoon discusses the outlook for cybersecurity stocks, as Amplify's Cybersecurity ETF (HACK) is up 8% year-to-date.
Why Investors Haven't Feasted on Two New Weight-Loss ETFs
Two new weight-loss exchange-traded funds (ETFs) launched in May have yet to whet investors' appetite, possibly due to their expensive fees and concentrated bets.